title: Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
abstract: Over-expression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is regarded as an early marker for several cancers. This protein is associated with proto-oncogenes and tumor suppressor genes and has itself been described as a proto-oncogene. Our earlier experiments drew a connection between hnRNP A2/B1 levels and cell proliferation and raised the possibility that this protein contributes to the uncontrolled cell division that characterizes cancer. Limited knowledge of the downstream targets of hnRNP A2/B1 has, however, precluded a clear understanding of their roles in cancer cell growth. To define the pathways in which this protein acts we have now carried out microarray experiments with total RNA from Colo16 epithelial cells transfected with an shRNA that markedly suppresses hnRNP A2/B1 expression. The microarray data identified 123 genes, among 22 283 human gene probe sets, with altered expression levels in hnRNP A2/B1-depleted cells. Ontological analysis showed that many of these downstream targets are involved in regulation of the cell cycle and cell proliferation and that this group of proteins is significantly over-represented amongst the affected proteins. The changes detected in the microarray experiments were confirmed by real-time PCR for a subset of proliferation-related genes. Immunoprecipitation-RT-PCR demonstrated that hnRNP A2/B1 formed complexes with the transcripts of many of the verified downstream genes, suggesting that hnRNP A2/B1 contributes to the regulation of these genes. These results reinforce the conclusion that hnRNP A2/B1 is associated with cellular processes that affect the cell cycle and proliferation.
authors.affiliation: School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Queensland, Australia.
authors.forename: Yaowu
authors.initials: Y
authors.lastname: He
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Rothnagel
authors.forename: Michael R
authors.initials: MR
authors.lastname: Epis
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Leedman
authors.forename: Ross
authors.initials: R
authors.lastname: Smith
mesh_terms: D001483:Base Sequence; D001665:Binding Sites; D015153:Blotting, Western; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D017931:DNA Primers; D020869:Gene Expression Profiling; D034481:Heterogeneous-Nuclear Ribonucleoprotein Group A-B / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D047468:Immunoprecipitation; D020411:Oligonucleotide Array Sequence Analysis; D000090063:Proto-Oncogene Mas; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D034481:Heterogeneous-Nuclear Ribonucleoprotein Group A-B; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; C439768:hnRNP A2